Author： Rapoport A.M. Tepper S.J. Bigal M.E. Sheftell F.D.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.17, Iss.6, 2003-01, pp. : 431-447
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. :
Access to resources
Recommend
By Sanjay G. K V. Gunjan K. R K. K T. A G. D W. Lourens Z.
International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 3, 2002-06 ,pp. :
Triptan use in France not currently ideal
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. :
Triptan use in migraine curbed by cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
Triptan use in France not currently ideal
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :